Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gabizon

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2A Cabanes, S Even-Chen, J Zimberoff, et al.
Seminars in Cancer Biology|December 25, 2019
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatmentNinh M La-Beck, Xinli Liu, Hilary Shmeeda, et al.
Biochimica Et Biophysica Acta|November 18, 1991
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation timesD D Lasic, F J Martin, A Gabizon, et al.
British Journal of Cancer|December 1, 1996
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studiesD Goren, A T Horowitz, S Zalipsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomesAlberto A Gabizon, Dinah Tzemach, Aviva T Horowitz, et al.
Cancer|July 3, 1999
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomesZ Symon, A Peyser, D Tzemach, et al.
Archives of Dermatology|December 15, 2000
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicinM Lotem, A Hubert, O Lyass, et al.
Journal of Neuro-Oncology|January 1, 1987
Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration studyT Siegal, U Sandbank, A Gabizon, et al.
Molecular Cancer Therapeutics|June 28, 2024
Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in SarcomasAntonia Charalambous, Fotios Mpekris, Myrofora Panagi, et al.
International Journal of Oncology|May 5, 2011
Hepatic arterial bolus chemotherapy for colorectal metastases using an implantable portS Lyass, O Lyass, A Gabizon, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2A Cabanes, S Even-Chen, J Zimberoff, et al.
Seminars in Cancer Biology|December 25, 2019
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatmentNinh M La-Beck, Xinli Liu, Hilary Shmeeda, et al.
Biochimica Et Biophysica Acta|November 18, 1991
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation timesD D Lasic, F J Martin, A Gabizon, et al.
British Journal of Cancer|December 1, 1996
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studiesD Goren, A T Horowitz, S Zalipsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomesAlberto A Gabizon, Dinah Tzemach, Aviva T Horowitz, et al.
Cancer|July 3, 1999
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomesZ Symon, A Peyser, D Tzemach, et al.
Archives of Dermatology|December 15, 2000
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicinM Lotem, A Hubert, O Lyass, et al.
Journal of Neuro-Oncology|January 1, 1987
Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration studyT Siegal, U Sandbank, A Gabizon, et al.
Molecular Cancer Therapeutics|June 28, 2024
Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in SarcomasAntonia Charalambous, Fotios Mpekris, Myrofora Panagi, et al.
International Journal of Oncology|May 5, 2011
Hepatic arterial bolus chemotherapy for colorectal metastases using an implantable portS Lyass, O Lyass, A Gabizon, et al.
Pageof 9